Stathmin guides personalized therapy in oral squamous cell carcinoma

The survival benefit from docetaxel, cisplatin and 5‐fluorouracil (TPF) induction chemotherapy in oral squamous cell carcinoma (OSCC) patients is not satisfactory. Previously, we identified that stathmin, a microtubule‐destabilizing protein, is overexpressed in OSCC. Here, we further investigated it...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Ju, Wu‐tong, Ma, Hai‐long, Zhao, Tong‐Chao, Liang, Si‐yuan, Zhu, Dong‐wang, Wang, Li‐zhen, Li, Jiang, Zhang, Zhi‐yuan, Zhou, Ge, Zhong, Lai‐ping
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7156844/
https://ncbi.nlm.nih.gov/pubmed/31994271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14323
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados